Aeterna Zentaris Releases AEZS-108 Safety, Efficacy Data
Aeterna Zentaris said that AEZS-108 is in a Phase 2 trial conducted in Europe by the German AGO Study Group (Study AGO-GYN5), in advanced ovarian and endometrial cancer,
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
Pro-Pointer said that Coenzyme-A Technologies is into the application of new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that